Enhanced hypoxia-stimulated erythropoietin production in mice with depression of erythropoiesis induced by hyperoxia

High Altitude Medicine and Biology

Volumn 4, Issue 1, 2003, Pages 73-79

  Bozzini, Carlos E ^a,b   Barceló, Ana C ^a   Conti, María I ^a   Martínez, María P ^a   Alippi, Rosa M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Bio Sidus   (Argentina)

Author keywords

Atmospheric air; Blood oxygen; Cytokine; Erythropoietin hypersecretory state; Red cell production

Indexed keywords

CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; IRON 59; TRACER;

AIRFLOW; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; HYPEROXIA; HYPOBARISM; HYPOXIA; IRON KINETICS; IRON TRANSPORT; LINEAR REGRESSION ANALYSIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEM CELL;

EID: 0037366807     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/152702903321489004     Document Type: Article

References (32)

1. Akahane K., Tojo A., Fukamachi H., Kitamuta T., Saito T., Urabe A., and Takaku F. (1989). Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions. Exp. Hematol. 117:177-182.
2. Barceló A.C., and Bozzini C.E. (1982). Erythropoietin formation during hypoxia in mice with impaired responsiveness to erythropoietin induced by irradiation or 5-fluorouracil injection. Experientia 38:504-505.
3. Beguin Y., Baron F., and Fillet G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica 83:1076-1081.
4. Birgegard G., Leif W., and Simonsson B. (1989). Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anemia for stimulation. Brit. J. Haematol. 72:462-466.
5. Bozzini C.E., Alippi R.M., Barceló A.C., Conti M.I., Lezón C.E., and Olivera M.I. (1994). The biology of stress erythropoiesis and erythropoietin production. Ann. N.Y. Acad. Sci. 718:83-93.
6. Cazzola M., Guarnone R., Cerani P., Centenara E., Rovati A., and Beguin Y. (1998). Red cell precursor mass as an independent determinant of serum erythropoietin level. Blood 91:2139-2145.
7. Chapel S., Veng-Pedersen P., Hohl R.J., Schmidt R.L., McGuire E.M., and Widness J.A. (1991). Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway. J Pharmacol Exp Ther 298:820-824.
8. Etckardt K.U., Dittmer J., Neumann R., Bauer C., and Kurtz A. (1990). Decline of erythropoietin formation at continuous hypoxia is not due to feedback inhibition. Am. J. Physiol. 258:F1427-F1437.
9. Fink S., Ray C.W., McCartney S., Ehrlich H., and Shoemaker W.C. (1984). Oxygen transport and utilization in hyperoxia and hypoxia: relation of conjunctival and transcutaneous oxygen tensions to hemodynamic and oxygen transport variables. Crit. Care Med. 12:943-948.
10. Fletcher J.W., Gallagher N.I., Warnecke M.A., and Donati R.M. (1973). Erythropoiesis and hyperoxia. Proc. Soc. Exp. Biol. Med. 144:569-574.
11. Fried W., Plzak L., Jacobson L.O., and Goldwasser E. (1957). Studies on erythropoiesis. III. Factors controlling erythropoietin production. Proc. Soc. Exp. Biol. Med. 94:237-241.
12. Fried W., Gregory S.A., Knospes W.H., and Trobaugh F.E. (1971). Regulation of plasma erythropoietin levels in mice with impaired responsiveness to erythropoietin. J. Lab. Clin. Med. 78:449-456.
13. Gottrup F., Gellet S., Kirkegaard L., Hansen E.S., and Johannsen G. (1988). Continuous monitoring of tissue tension during hyperoxia and hypoxia: relation of subcutaneous, transcutaneous, and conjunctival oxygen tension to hemodynamic variables. Crit. Care Med. 16:1229-1234.
14. Hammond G.D., Ishikawa A., and Keighley, G. (1962). Relationship between erythropoietin and severity of anemia in hypoplastic and hemolytic states. In Erythropoiesis, L.O. Jacobson and M. Doyle, eds. Grune and Stratton, New York, pp. 351-358.
15. 59 distribution. In: Erythropoiesis, L.O. Jacobson and M. Doyle, eds. Grune & Stratton, New York, pp. 222-227.
16. Jelkmann W., and Wiedemann G. (1990). Serum erythropoietin level: relationship to blood hemoglobin concentration and erythrocitic activity of the bone marrow. Klin. Wochenschr. 68:403-407.
17. Kaplan S.M., Piliero S.J., Gordon A.S., and Meagher R. (1977). Mechanisms underlying the suppression of erythropoiesis by hyperoxia. Am. J. Med. Sci. 273:71-77.
18. Kendall R.G., Cauill Y., and Norfolk D.R. (1994). Erythropoietin consumption during stimulated erythropoiesis. Ann. N.Y. Acad. Sci. 718:50-52.
19. Krantz S.B. (1991). Erythropoietin. Blood 77:419-434.
20. Kriymoski T., and Krzymowska. H. (1962). Studies on the erthropoiesis inhibiting factor in the plasma of animals with transfusion polycythermia. Blood 19:38-44.
21. Lezón C.E., Alippi R.M., Barceló A.C., Marténez M.P., Conti M.I., and Bozzini C.E. (1995). Depression of stimulated production of erythropoietin in mice with enhanced erythropoiesis. Haematologica 80:491-494.
22. Lezón C.E., Martínez M.P., Conti M.I., and Bozzini C.E. (1998). Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions. Endocrine 8:331-333.
23. Lindeman R. (1976). Erythopoiesis-inhibiting factor(s) (E1F): methodologic studies. Blood 47:155-163.
24. Linman J.W., and Pierre R.V. (1968). Studies on the erythropoietic effects of hyperbaric hyperbaria. Ann. N.Y. Acad. Sci. 149:25-33.
25. Martínez M.P., Conti M.I., Lezón C.E., Alippi R.M., and Bozzini C.E. (1996). Enhanced erythropoietin response to acute hypoxemia in mice with pharmacological depression of erythropoiesis. Hematology 1:247-252.
26. Moccia, G., Miller, M.E., Garcia, J.F., and Cronkite, E.P. (1980). The effect of plethora on erythropoietin levels. Proc. Soc. Exp. Biol. Med. 163:36-38.
27. Mufson R.A., and Gesner T.G. (1987). Binding and internalization of recombinant human erythropoietin in murine erythroid precursor cells. Blood 69:1485-1496.
28. Piroso E., Erslev A.J., Flaharty K.K., and Caro J. (1991). Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. Am. J. Haematol. 36:105-110.
29. Sawada K., Krantz S.B., Sawher S.T., and Civin C.I. (1988). Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells. J. Cell. Physiol. 137:337-344.
30. Stohlman F., and Brecher G. (1959). Humoral regulation of erythropoiesis. V. Relationship of plasma erythropoietin level to bone marrow activity. Proc. Soc. Exp. Biol. Med. 100:40-43.
31. Whitcomb W.H., Moore M., Dille R., Hummer L., and Bird R.M. (1965). Erythropoietin and erythropoiesis inhibitor activity in man. J. Clin. Invest. 44:1110-1116.
32. Youssoulfian H., Longmore G., Neumann D., Yoshimura A., and Lodish H.F. (1993). Structure, function, and activation of the erythropoietin receptor. Blood 81:2223-2236.